Composition: 1 ml of a sterile solution contains 0.1 ± 0.01 mg of CaCl2 and 10⁻¹⁰-10⁻¹¹ mg of the protein-peptide complex, from the spleen tissue of young gobies.
The physiological effect of viorgon-31 is associated with its ability to support the differentiation of T-cells and B-lymphocytes, to utilize red blood cells, to stimulate the production of erythropoietin, as well as factors that enhance the phagocytosis of immune cells, proliferation, differentiation and blast transformation of T-lymphocytes.
Indications for use: Viorgon-31 is recommended for infectious
Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.
Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.
A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.
The interval between the various viorgons is at least 10 minutes.